Back
Rocket Pharmaceuticals Vs. Lixte Biotechnology Holdings Industry Stock Comparison
Sell
5
RCKT
Rocket Pharmaceuticals
Last Price:
$2.46
Seasonality Move:
3.46%
Sell
24
LIXT
Lixte Biotechnology Holdings
Last Price:
$1.21
Seasonality Move:
15.27%
Sell
5
Rocket Pharmaceuticals (RCKT)
is a Sell
Is Rocket Pharmaceuticals a Buy, Sell or Hold?
-
The current Rocket Pharmaceuticals [RCKT] share price is $2.62. The Score for RCKT is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
-
RCKT is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
24
Lixte Biotechnology Holdings (LIXT)
is a Sell
Is Lixte Biotechnology Holdings a Buy, Sell or Hold?
-
The current Lixte Biotechnology Holdings [LIXT] share price is $1.25. The Score for LIXT is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
-
LIXT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RCKT Stock Price Chart
What is Rocket Pharmaceuticals's stock price today?
-
The Rocket Pharmaceuticals share price today is $2.62Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RCKT is experiencing buying pressure, which is a positive indicator for future bullish movement.
LIXT Stock Price Chart
What is Lixte Biotechnology Holdings's stock price today?
-
The Lixte Biotechnology Holdings share price today is $1.25Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LIXT is experiencing slight selling pressure.
RCKT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.91 | Sell |
Relative Strength Index (14 RSI): | 25.41 | Sell |
Chaikin Money Flow: | 6331935 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.88 - 7.96) | Sell |
Bollinger Bands (100): | (6.15 - 10.69) | Sell |
LIXT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 46.32 | Sell |
Chaikin Money Flow: | -3589 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.23 - 1.37) | Sell |
Bollinger Bands (100): | (1.05 - 2.11) | Sell |
RCKT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.02 | Sell |
20-day SMA: | 6.19 | Sell |
50-day SMA: | 6.54 | Sell |
200-day SMA: | 12.5 | Sell |
8-day EMA: | 4.41 | Sell |
20-day EMA: | 5.63 | Sell |
50-day EMA: | 6.76 | Sell |
200-day EMA: | 11.81 | Sell |
LIXT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.31 | Sell |
20-day SMA: | 1.3 | Sell |
50-day SMA: | 1.26 | Sell |
200-day SMA: | 1.74 | Sell |
8-day EMA: | 1.31 | Sell |
20-day EMA: | 1.3 | Sell |
50-day EMA: | 1.33 | Sell |
200-day EMA: | 1.76 | Sell |
Rocket Pharmaceuticals Earnings Growth & RCKT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.17 per share, an increase this year of $0.67 per share, and an increase next year of $0.68 per share.
Lixte Biotechnology Holdings Earnings Growth & LIXT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Rocket Pharmaceuticals Technical Analysis
May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
15 | 16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Lixte Biotechnology Holdings Technical Analysis
May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
15 | 16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |